MAIN's management group acquires diagnostic imaging business

TriMed Staff | | Health Imaging | Screening
MAIN (Mid-Atlantic Imaging Network) Medical's diagnostic imaging business has been acquired by the company's management and investment group. MAIN Medical, which operates medical imaging centers throughout Pennsylvania (Monroeville, Harmarville, Greensburg, West Mifflin, and Coraopolis) said it will maintain its headquarters in Pittsburgh.

While additional terms of the agreement were disclosed, the company said the acquisition includes the five imaging centers, plus the Mobile Ultrasound division that the former company operated, as well as retaining the rights to the MAIN Medical name. The new MAIN Medical will continue its growth by opening more centers and developing partnering relationships with hospitals and other imaging providers in the region.

According to CEO Anthony Geramita, stricter imaging guidelines recently issued by the region's largest insurer, Highmark, will fit well with the new company's operating plan. Highmark's new privileging guidelines require five modalities and a full-time radiologist.

TriMed Staff

Related Content

AI beats standard regression models at predicting lung cancer risk
AI reduces CT lung cancer screening workload by nearly 80%
Abbreviated MRI protocols present suitable alternatives for liver cancer screening
Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk

Around the web

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.